Search Results - "Boslett, James"

Refine Results
  1. 1
  2. 2

    Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall by Liu, Xiaoping, El-Mahdy, Mohamed A., Boslett, James, Varadharaj, Saradhadevi, Hemann, Craig, Abdelghany, Tamer M., Ismail, Raed S., Little, Sean C., Zhou, Danlei, Thuy, Le Thi Thanh, Kawada, Norifumi, Zweier, Jay L.

    Published in Nature communications (10-04-2017)
    “…The identity of the specific nitric oxide dioxygenase (NOD) that serves as the main in vivo regulator of O 2 -dependent NO degradation in smooth muscle remains…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides by Boslett, James, Helal, Moustafa, Chini, Eduardo, Zweier, Jay L.

    “…Following the onset of ischemia/reperfusion (I/R), CD38 activation occurs and is associated with depletion of NAD(P)(H) in the heart as well as myocardial…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Development of a fast‐scan EPR imaging system for highly accelerated free radical imaging by Samouilov, Alexandre, Ahmad, Rizwan, Boslett, James, Liu, Xiaoping, Petryakov, Sergey, Zweier, Jay L.

    Published in Magnetic resonance in medicine (01-08-2019)
    “…Purpose In continuous wave EPR imaging, the acquisition of high‐quality images was previously limited by the requisite long acquisition times of each image…”
    Get full text
    Journal Article
  7. 7

    Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart by Reyes, Levy A., Boslett, James, Varadharaj, Saradhadevi, De Pascali, Francesco, Hemann, Craig, Druhan, Lawrence J., Ambrosio, Giuseppe, El-Mahdy, Mohamed, Zweier, Jay L.

    “…In the postischemic heart, coronary vasodilation is impaired due to loss of endothelial nitric oxide synthase (eNOS) function. Although the eNOS cofactor…”
    Get full text
    Journal Article
  8. 8

    Mechanism by Which PF-3758309, a Pan Isoform Inhibitor of p21-Activated Kinases, Blocks Reactivation of HIV-1 Latency by Vargas, Benni, Boslett, James, Yates, Nathan, Sluis-Cremer, Nicolas

    Published in Biomolecules (Basel, Switzerland) (04-01-2023)
    “…The "block and lock" strategy is one approach that might elicit a sterilizing cure for HIV-1 infection. The "block" refers to a compound's ability to inhibit…”
    Get full text
    Journal Article
  9. 9

    Post‐ischemic Cardiac Protection by NADPH Supplementation or CD38 Inhibition is Dependent on Endothelial Nitric Oxide Synthase (eNOS) by Boslett, James, Zweier, Jay L.

    Published in The FASEB journal (01-04-2017)
    “…Introduction Recently, we showed that CD38 activation in myocardial ischemia/reperfusion (I/R) injury causes depletion of the NADP(H) pool of the heart with…”
    Get full text
    Journal Article
  10. 10

    Characterization of CD38 mRNA, Protein, and Enzyme Activity in the Cell Types of the Heart by Boslett, James, Zweier, Jay L.

    Published in The FASEB journal (01-04-2017)
    “…Introduction Recently, we showed that NAD(P) + ‐hydrolyzing CD38 is activated in myocardial ischemia/reperfusion (I/R) injury, leading to depletion of its…”
    Get full text
    Journal Article
  11. 11

    Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion by Boslett, James, Hemann, Craig, Christofi, Fedias L, Zweier, Jay L

    “…The NAD(P) -hydrolyzing enzyme CD38 is activated in the heart during the process of ischemia and reperfusion, triggering NAD(P)(H) depletion. However, the…”
    Get more information
    Journal Article
  12. 12

    Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury by Boslett, James, Reddy, Nikhil, Alzarie, Yasmin A, Zweier, Jay L

    “…Inhibition of and genetic deletion of the NAD(P) hydrolase [NAD(P)ase] CD38 have been shown to protect against ischemia/reperfusion (I/R) injury in rat and…”
    Get more information
    Journal Article
  13. 13

    Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H) by Boslett, James, Hemann, Craig, Zhao, Yong Juan, Lee, Hon-Cheung, Zweier, Jay L

    “…We recently showed that ischemia/reperfusion (I/R) of the heart causes CD38 activation with resultant depletion of the cardiac NADP(H) pool, which is most…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    Abstract 19525: Knockout of CD38 Preserves Endothelial Function in the Postischemic Heart through Reduced Nicotinamide Adenine Dinucleotide Phosphate Salvage by Boslett, James J, Chini, Eduardo N, Zweier, Jay

    Published in Circulation (New York, N.Y.) (25-11-2014)
    “…Abstract only Introduction: Cardiac ischemia/reperfusion (I/R) injury causes dysfunction in the coronary endothelium, resulting in loss of vascular relaxation…”
    Get full text
    Journal Article
  17. 17

    Acute BH4 depletion leads to a loss of myocardial protection conferred by cardiac‐specific overexpression of inducible nitric oxide synthase in mice (547.11) by Boslett, James, Barga, Elizabeth, Kotwal, Ameya, Choppara, Bhavana, Zweier, Jay

    Published in The FASEB journal (01-04-2014)
    “…Many studies have shown that cardiac overexpression of NOS enzymes can lead to myocardial protection against ischemia/reperfusion (I/R) injury. However, none…”
    Get full text
    Journal Article
  18. 18

    Acute BH 4 depletion leads to a loss of myocardial protection conferred by cardiac‐specific overexpression of inducible nitric oxide synthase in mice (547.11) by Boslett, James, Barga, Elizabeth, Kotwal, Ameya, Choppara, Bhavana, Zweier, Jay

    Published in The FASEB journal (01-04-2014)
    “…Abstract only Many studies have shown that cardiac overexpression of NOS enzymes can lead to myocardial protection against ischemia/reperfusion (I/R) injury…”
    Get full text
    Journal Article
  19. 19

    Luteolinidin, a naturally occurring flavonoid, decreases ischemia/reperfusion injury through inhibition of CD38 and preservation of NADPH and BH4 (547.14) by Boslett, James, De Pascali, Francesco, Hemann, Craig, Zweier, Jay

    Published in The FASEB journal (01-04-2014)
    “…CD38, a consumer of NAD+ and NADP+, is activated in I/R, leading to depletion of myocardial NADP(H) and consequently, lower eNOS function due to low levels of…”
    Get full text
    Journal Article
  20. 20

    Luteolinidin, a naturally occurring flavonoid, decreases ischemia/reperfusion injury through inhibition of CD38 and preservation of NADPH and BH 4 (547.14) by Boslett, James, De Pascali, Francesco, Hemann, Craig, Zweier, Jay

    Published in The FASEB journal (01-04-2014)
    “…Abstract only CD38, a consumer of NAD+ and NADP+, is activated in I/R, leading to depletion of myocardial NADP(H) and consequently, lower eNOS function due to…”
    Get full text
    Journal Article